MOXE HEALTH CORPORATION – Trademark Portfolio

Entity Type: 03

MOXE HEALTH CORPORATION holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include DROI, MOXE, SUBSTRATE, CONVERGENCE, and DIGITAL ROI. The owner is based in MADISON, WI.

228 N. Henry St., Suite 300

MADISON, WI 53703

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MOXE HEALTH CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (7 filings)

Scientific and technological services; industrial analysis and research services

38
Telecommunications (2 filings)

Telecommunications

Frequently Asked Questions

How many trademarks does MOXE HEALTH CORPORATION have?

MOXE HEALTH CORPORATION has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 cancelled.

What trademark classes does MOXE HEALTH CORPORATION file in?

MOXE HEALTH CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What are MOXE HEALTH CORPORATION's most well-known trademarks?

MOXE HEALTH CORPORATION's registered trademark portfolio includes well-known marks such as DROI, MOXE, SUBSTRATE, CONVERGENCE, and DIGITAL ROI. These are among 6 currently registered trademarks in the portfolio.

What is MOXE HEALTH CORPORATION's trademark registration success rate?

MOXE HEALTH CORPORATION has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.